Kibon Injection 1mcg 1ml Indications
Kibon Injection 1mcg 1ml (I.v) is primarily indicated in conditions like Hypocalc aemia, Hypophosphat aemia, Oncogenic hypophosphatemic osteomalacia, Renal tubular osteomalacia, Sporadic hypophosphatemic osteomalacia, Uraemic osteodystrophy, Uremic osteodystrophy, Vitamin D-dependent rickets, and can also be given in adjunctive therapy as an alternative drug of choice in Neon at al hypocalcemia, Osteomalacia, Osteomalacia in malabsorption syndrome, Osteoporosis, Psoriasis, Rickets in prem ature infants, X-linked hypophosphataemic osteomalacia.
The severe or irreversible adverse effects of Kibon Injection 1mcg 1ml (I.v), which give rise to further complications include Urinary calcium stone formation, Urinary calcium stone form ation.,Kibon Injection 1mcg 1ml (I.v) produces potentially lifethreatening effects which include Depression of CNS, Coma, Ectopic mineralization, which are responsible for the discontinuation of Kibon Injection 1mcg 1ml (I.v) therapy.,The signs and symptoms that are produced after the acute overdos age of Kibon Injection 1mcg 1ml (I.v) include latrogenic poisoning.
Kibon Injection 1mcg 1ml (I.v) is contraindicated in conditions like Hypercalcaemia
Kibon Injection 1mcg 1ml (I.v) administration in fortified food, diet and drugs. It may be necessary to limit diet ary Vit.D during treatment. If products of Vit.D contain tartrazine may cause allergic reaction (Including bronchial asthma) in susceptible individuals, Specially patients with aspirin hypersensitivity. 0 0 –